EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitochondrial peptide MOTS‐c suppresses systemic and cardiac inflammasome activation in a diabetic rat model

Aimee R Mills, Antonio de Souza, Toan Pham iD, Odunayo O Mugisho

Experimental Physiology · 2026-08 · 111 (8) · 3742-3752

DOI: 10.1113/ep093714 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Physiology, online erschienen am 19.06.2026. Verfasst von Aimee R Mills und 3 weiteren Autor:innen. Beteiligte Einrichtung: Buchanan Ocular Therapeutics Unit, Department of Ophthalmology, New Zealand National Eye Centre, University of Auckland, Auckland, New Zealand. Hauptthemen laut MEDLINE: Inflammasomes, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Mitochondrial Proteins. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heart Foundation of New Zealand Research Fellowship, Emerging Research First Grants, Health Research Council of New Zealand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2DM) is associated with chronic systemic and cardiac inflammation, contributing to the development of diabetic cardiomyopathy. The mitochondrial‐derived peptide mitochondrial open reading frame of the 12S rRNA type‐C (MOTS‐c) has emerged as a promising regulator of metabolic and inflammatory pathways. In this study, we investigated the effects of MOTS‐c treatment on leucine‐rich repeat and pyrin domain‐containing receptor 3 (NLRP3) inflammasome activity in a high‐fat diet and streptozotocin‐induced T2DM rat model. MOTS‐c treatment significantly reduced fasting blood glucose and circulating C‐reactive protein levels, while selectively modulating plasma inflammatory cytokines, including interleukin (IL)‐10 and IL‐1β. Immunohistochemical analysis revealed reduced levels of NLRP3, apoptosis‐associated speck‐like protein containing a caspase activation and recruitment domain (ASC), and cleaved caspase‐1 in left ventricular tissue following MOTS‐c administration. Correlation analyses linked IL‐18 and IL‐1β with elevated markers, including low‐density lipoprotein and uric acid, suggesting interplay between overall health and inflammasome activity. These results indicate that MOTS‐c modulates both systemic and cardiac inflammation in T2DM, providing a novel therapeutic approach for reducing cardiovascular risk in diabetic patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammasomesDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Mitochondrial ProteinsAnimalsMaleRatsNLR Family, Pyrin Domain-Containing 3 ProteinBlood GlucoseDiabetic CardiomyopathiesMyocardiumInterleukin-1betaRats, Sprague-DawleyInflammationDiet, High-FatCytokinesC-Reactive Protein

Stichwörter der Autor:innen

MOTS‐cdiabetic heartinflammasomeinflammation

Substanzen

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinMitochondrial ProteinsBlood GlucoseInterleukin-1betaNlrp3 protein, ratCytokinesC-Reactive Protein

Autor:innen und Institutionen

  • Buchanan Ocular Therapeutics Unit, Department of Ophthalmology, New Zealand National Eye Centre, University of Auckland, Auckland, New Zealand.
  • Centre for Brain Research, University of Auckland, Auckland, New Zealand.
  • Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
  • Department of Engineering Science and Biomedical Engineering, University of Auckland, Auckland, New Zealand.

ORCID-Profile: Toan Pham

Förderung

  • Heart Foundation of New Zealand Research Fellowship
  • Emerging Research First Grants
  • Health Research Council of New Zealand
  • Auckland Medical Research Foundation

Zitieren

APA

Mills, A. R., de Souza, A., Pham, T., & Mugisho, O. O. (2026). Mitochondrial peptide MOTS‐c suppresses systemic and cardiac inflammasome activation in a diabetic rat model. Experimental Physiology, 111(8), 3742-3752. https://doi.org/10.1113/ep093714

Vancouver

Mills AR, de Souza A, Pham T, Mugisho OO. Mitochondrial peptide MOTS‐c suppresses systemic and cardiac inflammasome activation in a diabetic rat model. Experimental Physiology. 2026;111(8):3742-3752. doi:10.1113/ep093714

BibTeX
@article{Mills2026,
  author = {Mills, Aimee R and de Souza, Antonio and Pham, Toan and Mugisho, Odunayo O},
  title = {Mitochondrial peptide MOTS‐c suppresses systemic and cardiac inflammasome activation in a diabetic rat model},
  journal = {Experimental Physiology},
  year = {2026},
  volume = {111},
  number = {8},
  pages = {3742--3752},
  doi = {10.1113/ep093714}
}
Kostenlos starten →